ATTENTION BHVN SHAREHOLDERS: Investors who lost money on Biohaven Ltd. are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESS Newswire / March 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd.
Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025
We recently published a list of 12 Stocks with Heavy Insider Buying in 2025. In this article, we are going to take a look at ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / March 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Biohaven Ltd. (NYSE:BHVN) Shares Purchased by Principal Financial Group Inc.
Principal Financial Group Inc. raised its holdings in Biohaven Ltd. (NYSE:BHVN – Free Report) by 4.4% in the 4th quarter, ...
Biohaven (NYSE:BHVN) Trading Down 6.1% After Earnings Miss
Biohaven Ltd. (NYSE:BHVN – Get Free Report) fell 6.1% during mid-day trading on Monday after the company announced weaker ...
Kalkine Media7d
Is Biohaven Ltd. (NYSE:BHVN) Sustaining Market Interest with New...
Highlights,Institutional firms have modified their holdings in Biohaven Ltd., contributing to shifts in stock ...
Estimating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Biohaven fair value estimate is US$28.35 With US$31.37 ...
Morningstar12d
Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
Optimized subcutaneous administration of BHV-1300 achieved rapid, deep and sustained lowering of IgG, differentiating Biohaven's new small molecule class of degraders from the monoclonal antibody ...